搜索结果：Cancer-Detecting

Automated breast cancer detection via computer vision techniques is challenging due to the complex nature of breast tissue, the subtle appearance of cancerous lesions, and variations in breast density. Mainstream techniques primarily focus on visual cues, overlooking complementary patient-specific textual features that are equally important and can enhance diagnostic accuracy. To address this gap, we introduce Multi-modal Cancer Detection Network (MMDCNet) that integrates visual cues with clinical data to improve breast cancer detection. Our approach processes medical images using computer vision techniques while structured patient metadata patterns are learned through a custom fully connected network. The extracted features are fused to form a comprehensive representation, allowing the model to leverage both visual and clinical information. The final classifier is trained based on the joint features embedding space of visual and clinical cues and experiments prove enhanced performance, improving accuracy from 79.38\% to 90.87\% on a Mini-DDSM dataset. Additionally, our approach achieves 97.05\% accuracy on an image-only dataset, highlighting the robustness and effectiveness of vis

Breast cancer is still the second top cause of cancer deaths worldwide and this emphasizes the importance of necessary steps for early detection. Traditional diagnostic methods, such as mammography, ultrasound, and thermography, which have limitations when it comes to catching subtle patterns and reducing false positives. New technologies like artificial intelligence (AI) and deep learning have brought about the revolution in medical imaging analysis. Nevertheless, typical architectures such as Convolutional Neural Networks (CNNs) often have problems with modeling long-range dependencies. It explores the application of visual transformer models (here: Swin Tiny, DeiT, BEiT, ViT, and YOLOv8) for breast cancer detection through a collection of mammographic image sets. The ViT model reached the highest accuracy of 99.32% which showed its superiority in detecting global patterns as well as subtle image features. Data augmenting approaches, such as resizing croppings, flippings, and normalization, were further applied to the model for achieving higher performance. Although there were interesting results, the issues of dataset diversity and model optimization which present new avenues of

Breast cancer is one of the deadliest cancers causing about massive number of patients to die annually all over the world according to the WHO. It is a kind of cancer that develops when the tissues of the breast grow rapidly and unboundly. This fatality rate can be prevented if the cancer is detected before it gets malignant. Using automation for early-age detection of breast cancer, Artificial Intelligence and Machine Learning technologies can be implemented for the best outcome. In this study, we are using the Breast Cancer Image Classification dataset collected from the Kaggle depository, which comprises 9248 Breast Ultrasound Images and is classified into three categories: Benign, Malignant, and Normal which refers to non-cancerous, cancerous, and normal images.This research introduces three pretrained model featuring custom classifiers that includes ResNet50, MobileNet, and VGG16, along with a custom CNN model utilizing the ReLU activation function.The models ResNet50, MobileNet, VGG16, and a custom CNN recorded accuracies of 98.41%, 97.91%, 98.19%, and 92.94% on the dataset, correspondingly, with ResNet50 achieving the highest accuracy of 98.41%.This model, with its deep and

In this paper we discuss lung cancer detection using hybrid model of Convolutional-Neural-Networks (CNNs) and Support-Vector-Machines-(SVMs) in order to gain early detection of tumors, benign or malignant. The work uses this hybrid model by training upon the Computed Tomography scans (CT scans) as dataset. Using deep learning for detecting lung cancer early is a cutting-edge method.

Breast cancer, the second leading cause of cancer-related deaths globally, accounts for a quarter of all cancer cases [1]. To lower this death rate, it is crucial to detect tumors early, as early-stage detection significantly improves treatment outcomes. Advances in non-invasive imaging techniques have made early detection possible through computer-aided detection (CAD) systems which rely on traditional image analysis to identify malignancies. However, there is a growing shift towards deep learning methods due to their superior effectiveness. Despite their potential, deep learning methods often struggle with accuracy due to the limited availability of large-labeled datasets for training. To address this issue, our study introduces a Contrastive Learning (CL) framework, which excels with smaller labeled datasets. In this regard, we train Resnet-50 in semi supervised CL approach using similarity index on a large amount of unlabeled mammogram data. In this regard, we use various augmentation and transformations which help improve the performance of our approach. Finally, we tune our model on a small set of labelled data that outperforms the existing state of the art. Specifically, we

Advances in healthcare research have significantly enhanced our understanding of disease mechanisms, diagnostic precision, and therapeutic options. Yet, lung cancer remains one of the leading causes of cancer-related mortality worldwide due to challenges in early and accurate diagnosis. While current lung cancer detection models show promise, there is considerable potential for further improving the accuracy for timely intervention. To address this challenge, we introduce a hybrid deep convolution model leveraging transfer learning, named the Maximum Sensitivity Neural Network (MSNN). MSNN is designed to improve the precision of lung cancer detection by refining sensitivity and specificity. This model has surpassed existing deep learning approaches through experimental validation, achieving an accuracy of 98% and a sensitivity of 97%. By overlaying sensitivity maps onto lung Computed Tomography (CT) scans, it enables the visualization of regions most indicative of malignant or benign classifications. This innovative method demonstrates exceptional performance in distinguishing lung cancer with minimal false positives, thereby enhancing the accuracy of medical diagnoses.

With the advances in artificial intelligence (AI), data-driven algorithms are becoming increasingly popular in the medical domain. However, due to the nonlinear and complex behavior of many of these algorithms, decision-making by such algorithms is not trustworthy for clinicians and is considered a black-box process. Hence, the scientific community has introduced explainable artificial intelligence (XAI) to remedy the problem. This systematic scoping review investigates the application of XAI in breast cancer detection and risk prediction. We conducted a comprehensive search on Scopus, IEEE Explore, PubMed, and Google Scholar (first 50 citations) using a systematic search strategy. The search spanned from January 2017 to July 2023, focusing on peer-reviewed studies implementing XAI methods in breast cancer datasets. Thirty studies met our inclusion criteria and were included in the analysis. The results revealed that SHapley Additive exPlanations (SHAP) is the top model-agnostic XAI technique in breast cancer research in terms of usage, explaining the model prediction results, diagnosis and classification of biomarkers, and prognosis and survival analysis. Additionally, the SHAP mo

Problem: Pancreas radiological imaging is challenging due to the small size, blurred boundaries, and variability of shape and position of the organ among patients. Goal: In this work we present MiniGPT-Pancreas, a Multimodal Large Language Model (MLLM), as an interactive chatbot to support clinicians in pancreas cancer diagnosis by integrating visual and textual information. Methods: MiniGPT-v2, a general-purpose MLLM, was fine-tuned in a cascaded way for pancreas detection, tumor classification, and tumor detection with multimodal prompts combining questions and computed tomography scans from the National Institute of Health (NIH), and Medical Segmentation Decathlon (MSD) datasets. The AbdomenCT-1k dataset was used to detect the liver, spleen, kidney, and pancreas. Results: MiniGPT-Pancreas achieved an Intersection over Union (IoU) of 0.595 and 0.550 for the detection of pancreas on NIH and MSD datasets, respectively. For the pancreas cancer classification task on the MSD dataset, accuracy, precision, and recall were 0.876, 0.874, and 0.878, respectively. When evaluating MiniGPT-Pancreas on the AbdomenCT-1k dataset for multi-organ detection, the IoU was 0.8399 for the liver, 0.722

Early detection is crucial for successful cancer treatment and increasing survivability rates, particularly in the most common forms. Ten different cancers have been identified in most of these advances that effectively use CNNs (Convolutional Neural Networks) for classification. The distinct architectures of CNNs used in each study concentrate on pattern recognition for different types of cancer across various datasets. The advantages and disadvantages of each approach are identified by comparing these architectures. This study explores the potential of integrating CNNs into clinical practice to complement traditional diagnostic methods. It also identifies the top-performing CNN architectures, highlighting their role in enhancing diagnostic capabilities in healthcare.

Lung cancer remains one of the leading causes of morbidity and mortality worldwide, making early diagnosis critical for improving therapeutic outcomes and patient prognosis. Computer-aided diagnosis systems, which analyze computed tomography images, have proven effective in detecting and classifying pulmonary nodules, significantly enhancing the detection rate of early-stage lung cancer. Although traditional machine learning algorithms have been valuable, they exhibit limitations in handling complex sample data. The recent emergence of deep learning has revolutionized medical image analysis, driving substantial advancements in this field. This review focuses on recent progress in deep learning for pulmonary nodule detection, segmentation, and classification. Traditional machine learning methods, such as support vector machines and k-nearest neighbors, have shown limitations, paving the way for advanced approaches like Convolutional Neural Networks, Recurrent Neural Networks, and Generative Adversarial Networks. The integration of ensemble models and novel techniques is also discussed, emphasizing the latest developments in lung cancer diagnosis. Deep learning algorithms, combined w

Colorectal cancer is the most common cancer in Singapore and the third most common cancer worldwide. Blood in a person's stool is a symptom of this disease, and it is usually detected by the faecal occult blood test (FOBT). However, the FOBT presents several limitations - the collection process for the stool samples is tedious and unpleasant, the waiting period for results is about 2 weeks and costs are involved. In this research, we propose a simple-to-use, fast and cost-free alternative - a stool recognition neural network that determines if there is blood in one's stool (which indicates a possible risk of colorectal cancer) from an image of it. As this is a new classification task, there was limited data available, hindering classifier performance. Hence, various Generative Adversarial Networks (GANs) (DiffAugment StyleGAN2, DCGAN, Conditional GAN) were trained to generate images of high fidelity to supplement the dataset. Subsequently, images generated by the GAN with the most realistic images (DiffAugment StyleGAN2) were concatenated to the classifier's training batch on-the-fly, improving accuracy to 94%. This model was then deployed to a mobile app - Poolice, where users can

Blood cancer can only be diagnosed properly if it is detected early. Each year, more than 1.24 million new cases of blood cancer are reported worldwide. There are about 6,000 cancers worldwide due to this disease. The importance of cancer detection and classification has prompted researchers to evaluate Deep Convolutional Neural Networks for the purpose of classifying blood cancers. The objective of this research is to conduct an in-depth investigation of the efficacy and suitability of modern Convolutional Neural Network (CNN) architectures for the detection and classification of blood malignancies. The study focuses on investigating the potential of Deep Convolutional Neural Networks (D-CNNs), comprising not only the foundational CNN models but also those improved through transfer learning methods and incorporated into ensemble strategies, to detect diverse forms of blood cancer with a high degree of accuracy. This paper provides a comprehensive investigation into five deep learning architectures derived from CNNs. These models, namely VGG19, ResNet152v2, SEresNet152, ResNet101, and DenseNet201, integrate ensemble learning techniques with transfer learning strategies. A compariso

This review article discusses the roles of federated learning (FL) and transfer learning (TL) in cancer detection based on image analysis. These two strategies powered by machine learning have drawn a lot of attention due to their potential to increase the precision and effectiveness of cancer diagnosis in light of the growing importance of machine learning techniques in cancer detection. FL enables the training of machine learning models on data distributed across multiple sites without the need for centralized data sharing, while TL allows for the transfer of knowledge from one task to another. A comprehensive assessment of the two methods, including their strengths, and weaknesses is presented. Moving on, their applications in cancer detection are discussed, including potential directions for the future. Finally, this article offers a thorough description of the functions of TL and FL in image-based cancer detection. The authors also make insightful suggestions for additional study in this rapidly developing area.

Science is about facts and truth. Yet sometimes the truth and facts are not obvious. For example, in the field of MRI (Magnetic Resonance Imaging), there has been a long-lasting debate about who were the major contributors in its development. Particularly, there was a strong dispute between the followers of two scientists, R. Damadian and P. Lauterbur. In this review, we carefully trace the major developments in applying NMR for cancer detection starting almost 50 years ago. The research records show that the truth was beyond the claims of either research camps. The development of NMR for cancer detection involved multiple research groups, who made critical contributions at different junctures.

Nanorobots are a promising development in targeted drug delivery and the treatment of neurological disorders, with potential for crossing the blood-brain barrier (BBB). These small devices leverage advancements in nanotechnology and bioengineering for precise navigation and targeted payload delivery, particularly for conditions like brain tumors, Alzheimer's disease, and Parkinson's disease. Recent progress in artificial intelligence (AI) and machine learning (ML) has improved the navigation and effectiveness of nanorobots, allowing them to detect and interact with cancer cells through biomarker analysis. This study presents a new reinforcement learning (RL) framework for optimizing nanorobot navigation in complex biological environments, focusing on cancer cell detection by analyzing the concentration gradients of surrounding biomarkers. We utilize a computer simulation model to explore the behavior of nanorobots in a three-dimensional space with cancer cells and biological barriers. The proposed method uses Q-learning to refine movement strategies based on real-time biomarker concentration data, enabling nanorobots to autonomously navigate to cancerous tissues for targeted drug d

Lung cancer is the leading cause of death among different types of cancers. Every year, the lives lost due to lung cancer exceed those lost to pancreatic, breast, and prostate cancer combined. The survival rate for lung cancer patients is very low compared to other cancer patients due to late diagnostics. Thus, early lung cancer diagnostics is crucial for patients to receive early treatments, increasing the survival rate or even becoming cancer-free. This paper proposed a deep-learning model for early lung cancer prediction and diagnosis from Computed Tomography (CT) scans. The proposed mode achieves high accuracy. In addition, it can be a beneficial tool to support radiologists' decisions in predicting and detecting lung cancer and its stage.

Breast cancer is a leading cause of cancer-related deaths, but current programs are expensive and prone to false positives, leading to unnecessary follow-up and patient anxiety. This paper proposes a solution to automated breast cancer detection, to improve the efficiency and accuracy of screening programs. Different methodologies were tested against the RSNA dataset of radiographic breast images of roughly 20,000 female patients and yielded an average validation case pF1 score of 0.56 across methods.

Objective: This paper proposes a deep learning model for breast cancer detection from reconstructed images of microwave imaging scan data and aims to improve the accuracy and efficiency of breast tumor detection, which could have a significant impact on breast cancer diagnosis and treatment. Methods: Our framework consists of different convolutional neural network (CNN) architectures for feature extraction and a region-based CNN for tumor detection. We use 7 different architectures: DenseNet201, ResNet50, InceptionV3, InceptionResNetV3, MobileNetV2, NASNetMobile and NASNetLarge and compare its performance to find the best architecture out of the seven. An experimental dataset of MRI-derived breast phantoms was used. Results: NASNetLarge is the best architecture which can be used for the CNN model with accuracy of 88.41% and loss of 27.82%. Given that the model's AUC is 0.786, it can be concluded that it is suitable for use in its present form, while it could be improved upon and trained on other datasets that are comparable. Impact: One of the main causes of death in women is breast cancer, and early identification is essential for enhancing the results for patients. Due to its non

Breast cancer is one of the most common and dangerous cancers in women, while it can also afflict men. Breast cancer treatment and detection are greatly aided by the use of histopathological images since they contain sufficient phenotypic data. A Deep Neural Network (DNN) is commonly employed to improve accuracy and breast cancer detection. In our research, we have analyzed pre-trained deep transfer learning models such as ResNet50, ResNet101, VGG16, and VGG19 for detecting breast cancer using the 2453 histopathology images dataset. Images in the dataset were separated into two categories: those with invasive ductal carcinoma (IDC) and those without IDC. After analyzing the transfer learning model, we found that ResNet50 outperformed other models, achieving accuracy rates of 90.2%, Area under Curve (AUC) rates of 90.0%, recall rates of 94.7%, and a marginal loss of 3.5%.